Publications by authors named "Simona Carnio"

Claim this Profile
C
Chemotherapy plus immunotherapy as first line combination in older patients with extensive stage small cell lung cancer: A systematic review and meta-analysis.
Valentina Bertaglia, Fausto Petrelli, Lorenzo Dottorini, Simona Carnio, Anna Maria Morelli

Semin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated non-small-cell lung cancer with brain metastases: A meta-analysis and systematic review.
Alessandro Nepote, Stefano Poletto, Valentina Bertaglia, Simona Carnio, Carlo Piumatti

Crit Rev Oncol Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of Supportive Care in Oncology.
Andrea Antonuzzo, Silvia Gonella, Livio Blasi, Simona Carnio, Ciro Franzese

Healthcare (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study).
Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, Luigi Cavanna, Olga Martelli, Simona Carnio

Sci Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Squamous cell histological transformation in a lung adenocarcinoma patient (hyper) progressing upon immunotherapy.
Annapaola Mariniello, Luisella Righi, Antonio Morrone, Simona Carnio, Paolo Bironzo

Tumori· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling.
Riccardo Caccialanza, Emanuele Cereda, Francesco Agustoni, Catherine Klersy, Amanda Casirati, Simona Carnio

BMC Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer.
Annapaola Mariniello, Fabrizio Tabbò, Davide Indellicati, Martina Tesauro, Nicole Alessia Rezmives, Simona Carnio

Cells· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study.
Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, Luigi Cavanna, Olga Martelli, Simona Carnio

BMC Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma.
Marco Tagliamento, Paolo Bironzo, Hubert Curcio, Emmanuele De Luca, Daniele Pignataro, Simona Carnio

Crit Rev Oncol Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Black Hairy Tongue After Immune Checkpoint Inhibitors in NSCLC: A Case Report and Review of the Literature.
Cristina Cecchi, Annapaola Mariniello, Simona Carnio, Marco D Delcuratolo, Silvia Novello

Clin Lung Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study.
Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, Luigi Cavanna, Olga Martelli, Simona Carnio

Oncologist· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics.
Laura Mezquita, Isabel Preeshagul, Edouard Auclin, Diana Saravia, Lizza Hendriks, Simona Carnio

Eur J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features.
Antonio Passaro, Silvia Novello, Diana Giannarelli, Emilio Bria, Domenico Galetta, Simona Carnio

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.
Alessio Cortellini, Katia Cannita, Marcello Tiseo, Diego L Cortinovis, Joachim G J V Aerts, Carnio Simona

Eur J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pericarditis during chemoimmunotherapy for non-small cell lung cancer: an adverse event to prevent and recognise.
Francesca Jacobs, Simona Carnio, Paola De Stefanis, Alessia Luciano, Silvia Novello

Eur J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave.
Valentina Bertaglia, Maria Lucia Reale, Paolo Bironzo, Erica Palesandro, Annapaola Mariniello, Simona Carnio

Crit Rev Oncol Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Alessio Cortellini, Marcello Tiseo, Giuseppe L Banna, Federico Cappuzzo, Joachim G J V Aerts, Simona Carnio

Cancer Immunol Immunother· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
Melissa Bersanelli, Diana Giannarelli, Ugo De Giorgi, Sandro Pignata, Massimo Di Maio, Simona Carnio

Ther Adv Med Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Arterial Hypertension in ALK Receptor Tyrosine Kinase-Positive Lung Cancer Patient: Adverse Event or Disease Spread?
Fabrizio Tabbò, Alessandro D'Aveni, Daniele Tota, Daniele Pignataro, Paolo Bironzo, Simona Carnio

J Thorac Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey.
Maria Vittoria Pacchiana, Enrica Capelletto, Simona Carnio, Cesare Gridelli, Antonio Rossi

Clin Lung Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatigue in lung cancer patients: symptom burden and management of challenges.
Simona Carnio, Rosario Francesco Di Stefano, Silvia Novello

Lung Cancer (Auckl)· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer.
Simona Carnio, Silvia Novello, Paolo Bironzo, Giorgio Vittorio Scagliotti

Expert Rev Anticancer Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extending survival of stage IV non-small cell lung cancer.
Simona Carnio, Silvia Novello, Teresa Mele, Matteo Giaj Levra, Giorgio Vittorio Scagliotti

Semin Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures.
Simona Carnio, Silvia Novello, Mauro Papotti, Marco Loiacono, Giorgio Vittorio Scagliotti

Transl Lung Cancer Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis